One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years’ Experience Provides Guidance for Management
Veronica Dusi, MD, P HD, a,b Luigi Pugliese, MD,c Gaetano M. De Ferrari, MD,b Attilio Odero, MD, d Lia Crotti, MD, PH D, a,e,f,g Federica Dagradi, MD, a Silvia Castelletti, MD, a Alessandro Vicentini, MD, h Roberto Rordorf, MD,h Cuilan Li, PH D, i Maria Shkolnikova, MD, j Carla Spazzolini, DVM, MS, a Peter J. Schwartz, MD
doi : 10.1016/j.jacep.2021.09.002
Volume 8, Issue 3, March 2022, Pages 281-294
This study sought to report our single-center experience with left cardiac sympathetic denervation (LCSD) for long QT syndrome (LQTS) since 1973.
Cardiac Sympathectomy and its Enduring Value for the Management of Long QT Syndrome∗
Kalyanam Shivkumar, MD, PH D, a Douglas P. Zipes, MD
doi : 10.1016/j.jacep.2021.11.004
Volume 8, Issue 3, March 2022, Pages 295-296
Association Between Deleterious SCN5A Variants and Ventricular Septal Defect in Young Patients With Brugada Syndrome
Keisuke Suzuki, MD, a,b Keiko Sonoda, MD, PH D, c,d Hisaaki Aoki, MD, P HD, e Yuko Nakamura, MD, f Seiichi Watanabe, MD, f Yoko Yoshida, MD, P HD, g Kenji Hoshino, MD, PHD, h Junichi Ozawa, MD, PH D, i Tomohiko Imamura, MD,j,k Takeshi Aiba, MD, PH D, l Koichi Kato, MD, PHD, d Takeru Makiyama, MD, P HD, k Kengo Kusano, MD, PHD, l Minoru Horie, MD, PHD, d Seiko Ohno, MD, P HD
doi : 10.1016/j.jacep.2022.01.007
Volume 8, Issue 3, March 2022, Pages 297-305
This study aimed to investigate the clinical characteristics of young patients with Brugada syndrome (BrS) with ventricular septal defect (VSD) and explore their genetic backgrounds.
Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy
Robert W. Roudijk, MD,a,b Lisa Verheul, MD,a Laurens P. Bosman, MD, a,b Mimount Bourfiss, MD,a Johannes M.P.J. Breur, MD, PH D, c Martijn G. Slieker, MD, P HD, c Andreas C. Blank, MD, PH D, c Dennis Dooijes, PHD, d Jeroen F. van der Heijden, MD, PHD, a Freek van den Heuvel, MD, PH D, e Sally-Ann Clur, MD, P HD, f Floris E.A. Udink ten Cate, MD, P HD, g Maarten P. van den Berg, MD, P HD, h Arthur A.M. Wilde, MD, PHD, i Folkert W. Asselbergs, MD, PHD, a,j,k J. Peter van Tintelen, MD, P HD, b,d Anneline S.J.M. te Riele, MD, PH D
doi : 10.1016/j.jacep.2021.09.001
Volume 8, Issue 3, March 2022, Pages 306-318
The goal of this study was to describe characteristics, cascade screening results, and predictors of adverse outcome in pediatric-onset arrhythmogenic right ventricular cardiomyopathy (ARVC).
Pediatric Arrhythmogenic Right Ventricular Cardiomyopathy: They May Be Small, But They Pack a Big Punch∗
M. Cecilia Gonzalez Corcia, MD, PHD, a Kara S. Motonaga, MD
doi : 10.1016/j.jacep.2021.09.014
Volume 8, Issue 3, March 2022, Pages 319-321
Multicenter Outcomes of Catheter Ablation for Atrioventricular Reciprocating Tachycardia Mediated by Twin Atrioventricular Nodes
Jeremy P. Moore, MD, MS, a,b,c Roberto G. Gallotti, MD, a,b,c Kevin M. Shannon, MD,a,b,c Benjamin A. Blais, MD,c Elizabeth S. DeWitt, MD, d Shuenn-Nan Chiu, MD, PH D, e David S. Spar, MD,f Frank A. Fish, MD,g Maully J. Shah, MBBS,h Sabine Ernst, MD, P HD, i Paul Khairy, MD, PHD, j Ronald J. Kanter, MD, k Philip M. Chang, MD,l Thomas Pilcher, MD,m Ian H. Law, MD,n Eric S. Silver, MD,o Mei-Hwan Wu, MD, PHD
doi : 10.1016/j.jacep.2021.08.004
Volume 8, Issue 3, March 2022, Pages 322-330
This study sought to describe the electrophysiologic properties and catheter ablation outcomes for atrioventricular reciprocating tacchycardia via twin atrioventricular nodes (T-AVRT).
Incidence, Risk Factors, and Outcomes of Atrial Arrhythmias in Adult Patients With Atrioventricular Septal Defect
Etienne Jacquemart, MD, MPH,a,b,c Francis Bessière, MD, PHD, d Nicolas Combes, MD,e,f Magalie Ladouceur, MD, PHD, b,c Laurence Iserin, MD, b Kevin Gardey, MD, d Roland Henaine, MD, PH D, d Arnaud Dulac, MD, d Sarah Cohen, MD, P HD, e Emre Belli, MD, e Anne-Sophie Jannot, MD, PHD, g Philippe Chevalier, MD, P HD, d Reaksmei Ly, MD, b Sandra Clavier, MD, b Antoine Legendre, MD,b Jérôme Petit, MD,e Alice Maltret, MD, e Sylvie Di Filippo, MD, P HD, d Sébastien Hascoët, MD, PHD, e Eloi Marijon, MD, P HD, a,c Victor Waldmann, MD, PHD
doi : 10.1016/j.jacep.2021.09.004
Volume 8, Issue 3, March 2022, Pages 331-340
Age Matters: Atrial Arrhythmias in Adult Patients With Atrioventricular Septal Defect∗
Ulrich Krause, MD
doi : 10.1016/j.jacep.2021.11.013
Volume 8, Issue 3, March 2022, Pages 341-342
Lead Extraction at a Pediatric/Congenital Heart Disease Center: The Importance of Patient Age at Implant
Tam Dan N. Pham, MD,a, * Frank Cecchin, MD,a,y Edward O’Leary, MD,a Francis Fynn-Thompson, MD, b John K. Triedman, MD, a Kimberlee Gauvreau, S CD, a Douglas Y. Mah, MD
doi : 10.1016/j.jacep.2021.11.008
Volume 8, Issue 3, March 2022, Pages 343-353
This study sought to evaluate the safety and efficacy of transvenous lead extraction (TLE) at a single pediatric/congenital heart disease (CHD) center.
Incremental Progress in Lead Extraction Risk Stratification: Outcomes Data From a Pediatric/Congenital Population∗
Aron Bender, MD, Noel G. Boyle, MD, PHD
doi : 10.1016/j.jacep.2022.01.023
Volume 8, Issue 3, March 2022, Pages 354-355
Postmortem Interrogation of Cardiac Implantable Electronic Devices: A 15-Year Experience
Elizabeth D. Paratz, MBBS (H ONS), BM ED SC,a,b,c Tomasz J. Block, MBBS, BB IOMEDSCI (HONS), d,e Dion A. Stub, MBBS, P HD, b,f,g Andre La Gerche, MBBS, PHD, a,b,c Peter M. Kistler, MBBS, PHD, a,b,g,h Jonathan M. Kalman, MBBS, PHD, h,i Neil Strathmore, MBBS, BS CI,h,i Harry Mond, MBBS, P HD, MD, h,i Noel W.F. Woodford, MBBS, LLM, j,k Michael Burke, MBBS, BSCI, j,k Aleksandr Voskoboinik, MBBS, PHD
doi : 10.1016/j.jacep.2021.10.011
Volume 8, Issue 3, March 2022, Pages 356-366
This study sought to define the feasibility and utility of postmortem cardiac implantable electronic device (CIED) interrogation.
Vein of Marshall Ethanol Infusion as First Step for Mitral Isthmus Linear Ablation
Kris Gillis, MD, PHD, Louisa O’Neill, MD, P HD, Jean-Yves Wielandts, MD, MSC , PH D, Gabriela Hilfiker, MD, Alexandre Almorad, MD, Michelle Lycke, MS C, P HD, Milad El Haddad, PHD, Jean-Benoît le Polain de Waroux, MD, PHD, Rene Tavernier, MD, PH D, Mattias Duytschaever, MD, PH D, Sebastien Knecht, MD, PH D
doi : 10.1016/j.jacep.2021.11.019
Volume 8, Issue 3, March 2022, Pages 367-376
In this study, the authors sought to investigate the added value of vein of Marshall ethanol infusion (VOMEt) as first step in facilitating radiofrequency (RF)–guided mitral isthmus (MI) block.
Alternative Approaches for Ablation of the Mitral Isthmus for Treatment of Atrial Fibrillation∗
Gregory K. Feld, MD
doi : 10.1016/j.jacep.2021.12.003
Volume 8, Issue 3, March 2022, Pages 377-379
Premature Ventricular Contraction-Triggered Ventricular Fibrillation and Sudden Cardiac Arrest in the Young
Adi Lador, MDy John R. Giudicessi, MD, PhDy Walid M. Barake, MBBCh Peter A. Noseworthy, MD Suraj Kapa, MD Christopher J. McLeod, MBChB, PhD Bryan C. Cannon, MD Samuel J. Asirvatham, MD *Michael J. Ackerman, MD, PhD
doi : 10.1016/j.jacep.2021.09.016
Volume 8, Issue 3, March 2022, Pages 380-382
Rural-Urban Temporal Trends for Sudden Cardiac Death in the United States, 1999-2019
Zachary H. Hughes, MD Nilay S. Shah, MD, MPH Yoshihiro Tanaka, MD, PhD Michael M. Hammond, MD, MPH Rod Passman, MD, MSCE *Sadiya S. Khan, MD, MSc
doi : 10.1016/j.jacep.2021.12.006
Volume 8, Issue 3, March 2022, Pages 382-384
A New Method for Supine 12-Leads Electrocardiogram
Jesús Diz-DÃaz, MD Fabián Islas, MD *Miguel Ã�ngel Cobos Gil, MD, PhD * Servicio de CardiologÃa
doi : 10.1016/j.jacep.2022.01.021
Volume 8, Issue 3, March 2022, Pages 384-385
The Authors’ Reply
David Chieng, MBBS *Peter M. Kistler, MBBS, PhD
doi : 10.1016/j.jacep.2022.01.022
Volume 8, Issue 3, March 2022, Page 385
Brugada Syndrome
Andrew D. Krahn, MD, a Elijah R. Behr, MBBS MD,b Robert Hamilton, MD, MHS C, c Vincent Probst, MD, PH D, d Zachary Laksman, MD, MS C,a Hui-Chen Han, MBBS, PH D a,
doi : 10.1016/j.jacep.2021.12.001
Volume 8, Issue 3, March 2022, Pages 386-405
Brugada syndrome (BrS) is an “inherited� condition characterized by predisposition to syncope and cardiac arrest, predominantly during sleep. The prevalence is ∼1:2,000, and is more commonly diagnosed in young to middle-aged males, although patient sex does not appear to impact prognosis.
Left Bundle Branch Optimized Cardiac Resynchronization Therapy in Mesocardia With Bilateral Superior Vena Cava
Shunmuga Sundaram Ponnusamy, MD, DM,a Thabish Syed, MBBS, DNB, a William Basil, BE
doi : 10.1016/j.jacep.2021.09.005
Volume 8, Issue 3, March 2022, Pages 406-409
